
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7234588
[patent_doc_number] => 20050256208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Pharmaceutical composition containing bakuchiol for treating woman breast cancer'
[patent_app_type] => utility
[patent_app_number] => 11/126225
[patent_app_country] => US
[patent_app_date] => 2005-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3926
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256208.pdf
[firstpage_image] =>[orig_patent_app_number] => 11126225
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/126225 | Pharmaceutical composition containing bakuchiol for treating woman breast cancer | May 10, 2005 | Abandoned |
Array
(
[id] => 5085883
[patent_doc_number] => 20070275934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments'
[patent_app_type] => utility
[patent_app_number] => 11/596330
[patent_app_country] => US
[patent_app_date] => 2005-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14896
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275934.pdf
[firstpage_image] =>[orig_patent_app_number] => 11596330
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/596330 | Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments | May 9, 2005 | Abandoned |
Array
(
[id] => 5005537
[patent_doc_number] => 20070203109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Compounds And Compositions For Treatment Of Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/568633
[patent_app_country] => US
[patent_app_date] => 2005-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8012
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20070203109.pdf
[firstpage_image] =>[orig_patent_app_number] => 11568633
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/568633 | Compounds And Compositions For Treatment Of Cancer | May 5, 2005 | Abandoned |
Array
(
[id] => 7224506
[patent_doc_number] => 20050261260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Combination of a CDK inhibitor and mitoxantrone'
[patent_app_type] => utility
[patent_app_number] => 11/124636
[patent_app_country] => US
[patent_app_date] => 2005-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6342
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20050261260.pdf
[firstpage_image] =>[orig_patent_app_number] => 11124636
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/124636 | Combination of a CDK inhibitor and mitoxantrone | May 4, 2005 | Abandoned |
Array
(
[id] => 7055692
[patent_doc_number] => 20050276866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-15
[patent_title] => 'Combination comprising a CDK inhibitor and cisplatin'
[patent_app_type] => utility
[patent_app_number] => 11/121753
[patent_app_country] => US
[patent_app_date] => 2005-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5699
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20050276866.pdf
[firstpage_image] =>[orig_patent_app_number] => 11121753
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/121753 | Combination comprising a CDK inhibitor and cisplatin | May 2, 2005 | Abandoned |
Array
(
[id] => 7051384
[patent_doc_number] => 20050187271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid and/or its physiologically tolerable salts as a cancer-fighting agent'
[patent_app_type] => utility
[patent_app_number] => 11/117569
[patent_app_country] => US
[patent_app_date] => 2005-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2422
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187271.pdf
[firstpage_image] =>[orig_patent_app_number] => 11117569
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/117569 | Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid and/or its physiologically tolerable salts as a cancer-fighting agent | Apr 28, 2005 | Abandoned |
Array
(
[id] => 7051297
[patent_doc_number] => 20050187184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Antineoplastic combinations'
[patent_app_type] => utility
[patent_app_number] => 11/110050
[patent_app_country] => US
[patent_app_date] => 2005-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4694
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187184.pdf
[firstpage_image] =>[orig_patent_app_number] => 11110050
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/110050 | Antineoplastic combinations | Apr 19, 2005 | Abandoned |
Array
(
[id] => 5189219
[patent_doc_number] => 20070167528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Methods of treating hepatocellular carcinoma with denspm'
[patent_app_type] => utility
[patent_app_number] => 11/548000
[patent_app_country] => US
[patent_app_date] => 2005-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3195
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167528.pdf
[firstpage_image] =>[orig_patent_app_number] => 11548000
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/548000 | Methods of treating hepatocellular carcinoma with denspm | Apr 11, 2005 | Abandoned |
Array
(
[id] => 5199784
[patent_doc_number] => 20070299102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer'
[patent_app_type] => utility
[patent_app_number] => 10/599121
[patent_app_country] => US
[patent_app_date] => 2005-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 26904
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20070299102.pdf
[firstpage_image] =>[orig_patent_app_number] => 10599121
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/599121 | Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer | Apr 7, 2005 | Abandoned |
Array
(
[id] => 5211055
[patent_doc_number] => 20070249639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'Use of 9H-Purine-2,6-Diamine Derivatives in the Treatment of Proliferative Diseases and Novel 9H-Purine-2,6-Diamine Derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/594412
[patent_app_country] => US
[patent_app_date] => 2005-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18572
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20070249639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594412
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594412 | Use of 9H-Purine-2,6-Diamine Derivatives in the Treatment of Proliferative Diseases and Novel 9H-Purine-2,6-Diamine Derivatives | Apr 3, 2005 | Abandoned |
Array
(
[id] => 5786760
[patent_doc_number] => 20060205757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => '39-desmethoxyrapamycin, compositions and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/097605
[patent_app_country] => US
[patent_app_date] => 2005-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13090
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205757.pdf
[firstpage_image] =>[orig_patent_app_number] => 11097605
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/097605 | 39-desmethoxyrapamycin, compositions and methods of use thereof | Mar 31, 2005 | Issued |
Array
(
[id] => 6959626
[patent_doc_number] => 20050215593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Methods treating tumors with thalidomide'
[patent_app_type] => utility
[patent_app_number] => 11/096155
[patent_app_country] => US
[patent_app_date] => 2005-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6316
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20050215593.pdf
[firstpage_image] =>[orig_patent_app_number] => 11096155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/096155 | Methods for inhibiting undesired angiogenesis in patients having tumors with thalidomide | Mar 30, 2005 | Issued |
Array
(
[id] => 7020230
[patent_doc_number] => 20050222249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Softgel of NLKJ for treating prostate diseases'
[patent_app_type] => utility
[patent_app_number] => 11/099780
[patent_app_country] => US
[patent_app_date] => 2005-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1638
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222249.pdf
[firstpage_image] =>[orig_patent_app_number] => 11099780
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/099780 | Softgel of NLKJ for treating prostate diseases | Mar 27, 2005 | Issued |
Array
(
[id] => 7020230
[patent_doc_number] => 20050222249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Softgel of NLKJ for treating prostate diseases'
[patent_app_type] => utility
[patent_app_number] => 11/099780
[patent_app_country] => US
[patent_app_date] => 2005-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1638
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222249.pdf
[firstpage_image] =>[orig_patent_app_number] => 11099780
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/099780 | Softgel of NLKJ for treating prostate diseases | Mar 27, 2005 | Issued |
Array
(
[id] => 4887682
[patent_doc_number] => 20080262014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Use of Camptothecin Derivatives for the Treatment of Proliferative Diseases in a Fixed Dosing Regimen'
[patent_app_type] => utility
[patent_app_number] => 10/592832
[patent_app_country] => US
[patent_app_date] => 2005-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2118
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20080262014.pdf
[firstpage_image] =>[orig_patent_app_number] => 10592832
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/592832 | Use of Camptothecin Derivatives for the Treatment of Proliferative Diseases in a Fixed Dosing Regimen | Mar 23, 2005 | Abandoned |
Array
(
[id] => 4740651
[patent_doc_number] => 20080234304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'N3-Pyridyl-Thiamine And Its Use In Cancer Treatments'
[patent_app_type] => utility
[patent_app_number] => 10/594191
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 7068
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234304.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594191
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594191 | N3-Pyridyl-Thiamine And Its Use In Cancer Treatments | Mar 22, 2005 | Abandoned |
Array
(
[id] => 4846458
[patent_doc_number] => 20080182866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'Tetra-Cyclic Carboline Derivatives Useful in the Inhibition of Angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 10/592761
[patent_app_country] => US
[patent_app_date] => 2005-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11998
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20080182866.pdf
[firstpage_image] =>[orig_patent_app_number] => 10592761
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/592761 | Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis | Mar 14, 2005 | Issued |
Array
(
[id] => 4613312
[patent_doc_number] => 07989468
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-02
[patent_title] => 'Methods of using SNS-595'
[patent_app_type] => utility
[patent_app_number] => 11/080283
[patent_app_country] => US
[patent_app_date] => 2005-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4003
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/989/07989468.pdf
[firstpage_image] =>[orig_patent_app_number] => 11080283
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/080283 | Methods of using SNS-595 | Mar 13, 2005 | Issued |
Array
(
[id] => 4432249
[patent_doc_number] => 07968565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-28
[patent_title] => 'Therapeutic combinations comprising (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid'
[patent_app_type] => utility
[patent_app_number] => 11/080102
[patent_app_country] => US
[patent_app_date] => 2005-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7370
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/968/07968565.pdf
[firstpage_image] =>[orig_patent_app_number] => 11080102
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/080102 | Therapeutic combinations comprising (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid | Mar 13, 2005 | Issued |
Array
(
[id] => 7250786
[patent_doc_number] => 20050272758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Antineoplastic combinations of CCI-779 and rituximab'
[patent_app_type] => utility
[patent_app_number] => 11/075509
[patent_app_country] => US
[patent_app_date] => 2005-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2754
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272758.pdf
[firstpage_image] =>[orig_patent_app_number] => 11075509
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/075509 | Antineoplastic combinations of CCI-779 and rituximab | Mar 8, 2005 | Abandoned |